Intensity Therapeutics INTS
NASDAQ INTS
$3.19 -0.09 (-2.72%)
As of: Oct 21, 2026 · 2:01 PM EDT

Intensity Therapeutics (INTS) Other financing activities (2023 - 2026)

Updated

Intensity Therapeutics (INTS) reported Other financing activities of $1.95 million for Q3 2023.

Analysis

Intensity Therapeutics (INTS) Other financing activities (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.90 Bn 1,102.48 Bn 19.71 Bn
2 Johnson & Johnson 616.46 Bn 534.99 Bn 17.26 Bn
3 AbbVie 501.26 Bn 474.37 Bn 12.70 Bn
4 Merck 367.00 Bn 321.38 Bn 12.21 Bn
5 Novartis Ag 297.91 Bn 261.90 Bn 11.24 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn
7 Amgen 235.82 Bn 191.22 Bn 7.24 Bn
8 Gilead Sciences 190.63 Bn 164.82 Bn 6.22 Bn
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn
10 Intensity Therapeutics 8.63 Mn -30.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -60,000.00
Mar 31, 2026 -7,000.00
Dec 31, 2025 -565,000.00
Sep 30, 2025 -301,000.00
Jun 30, 2025 -933,000.00
Mar 31, 2025 -17,000.00
Dec 31, 2024 -571,000.00
Sep 30, 2024 -82,000.00
Dec 31, 2023 -2.23 Mn
Sep 30, 2023 279,338.00
API Access

Intensity Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=INTS&period=max&api_key=YOUR_API_KEY